
Lawrence E. Anderson
Examiner (ID: 8007)
| Most Active Art Unit | 2301 |
| Art Unit(s) | 2302, 2301, 2308 |
| Total Applications | 332 |
| Issued Applications | 188 |
| Pending Applications | 0 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17474205
[patent_doc_number] => 20220081709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => IN-VITRO METHOD FOR DETECTING AT LEAST ONE NUCLEIC ACID, WHICH IS LOCATED OUTSIDE THE BLOOD CELLS IN WHOLE BLOOD IN THE CASE OF A LIVING BEING, AND DEVICE AND KIT FOR THIS PURPOSE
[patent_app_type] => utility
[patent_app_number] => 17/414146
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414146 | IN-VITRO METHOD FOR DETECTING AT LEAST ONE NUCLEIC ACID, WHICH IS LOCATED OUTSIDE THE BLOOD CELLS IN WHOLE BLOOD IN THE CASE OF A LIVING BEING, AND DEVICE AND KIT FOR THIS PURPOSE | Dec 17, 2019 | Abandoned |
Array
(
[id] => 17428803
[patent_doc_number] => 20220056511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => METHODS AND COMPOSITIONS TO REDUCE NONSPECIFIC AMPLIFICATION IN ISOTHERMAL AMPLIFICATION REACTIONS
[patent_app_type] => utility
[patent_app_number] => 17/416105
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416105 | METHODS AND COMPOSITIONS TO REDUCE NONSPECIFIC AMPLIFICATION IN ISOTHERMAL AMPLIFICATION REACTIONS | Dec 17, 2019 | Abandoned |
Array
(
[id] => 17274731
[patent_doc_number] => 20210380929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS
[patent_app_type] => utility
[patent_app_number] => 17/287214
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287214 | METHODS, APPARATUS AND KITS FOR BACTERIAL CELL LYSIS | Nov 5, 2019 | Pending |
Array
(
[id] => 17336451
[patent_doc_number] => 20220002782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHOD FOR PREPARING NUCLEIC ACID DERIVED FROM SKIN CELL OF SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/289915
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289915 | METHOD FOR PREPARING NUCLEIC ACID DERIVED FROM SKIN CELL OF SUBJECT | Oct 31, 2019 | Pending |
Array
(
[id] => 17344038
[patent_doc_number] => 20220010369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD AND APPARATUS FOR PERFORMING A REAL-TIME COLORIMETRIC NUCLEIC ACID AMPLIFICATION ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/282729
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282729 | METHOD AND APPARATUS FOR PERFORMING A REAL-TIME COLORIMETRIC NUCLEIC ACID AMPLIFICATION ASSAY | Oct 30, 2019 | Pending |
Array
(
[id] => 17642359
[patent_doc_number] => 20220170097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => CAR T CELL TRANSCRIPTIONAL ATLAS
[patent_app_type] => utility
[patent_app_number] => 17/289844
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 207899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289844 | CAR T CELL TRANSCRIPTIONAL ATLAS | Oct 28, 2019 | Pending |
Array
(
[id] => 17292592
[patent_doc_number] => 20210388431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => THERMOKINETICALLY BALANCED ISOTHERMAL AMPLIFICATION OF NUCLEIC ACID SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/290186
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290186
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290186 | THERMOKINETICALLY BALANCED ISOTHERMAL AMPLIFICATION OF NUCLEIC ACID SEQUENCES | Oct 27, 2019 | Pending |
Array
(
[id] => 20608580
[patent_doc_number] => 12584172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Chromosome biomarker
[patent_app_type] => utility
[patent_app_number] => 17/287092
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 67696
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287092 | Chromosome biomarker | Oct 20, 2019 | Issued |
Array
(
[id] => 17170813
[patent_doc_number] => 20210324483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR MEASURING THE INFECTIVITY OF REPLICATION DEFECTIVE VIRAL VECTORS AND VIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/285362
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285362
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285362 | METHOD FOR MEASURING THE INFECTIVITY OF REPLICATION DEFECTIVE VIRAL VECTORS AND VIRUSES | Oct 13, 2019 | Pending |
Array
(
[id] => 17037222
[patent_doc_number] => 20210254180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => METHOD FOR THE PROGNOSIS OF MELANOMA
[patent_app_type] => utility
[patent_app_number] => 17/282198
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282198 | METHOD FOR THE PROGNOSIS OF MELANOMA | Oct 2, 2019 | Abandoned |
Array
(
[id] => 17400025
[patent_doc_number] => 20220042115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => ROTAVIRUS GENOTYPE DETECTION METHOD, AND GENE AMPLIFICATION PRIMER SET USED IN SAME
[patent_app_type] => utility
[patent_app_number] => 17/277069
[patent_app_country] => US
[patent_app_date] => 2019-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277069 | ROTAVIRUS GENOTYPE DETECTION METHOD, AND GENE AMPLIFICATION PRIMER SET USED IN SAME | Oct 1, 2019 | Pending |
Array
(
[id] => 20330005
[patent_doc_number] => 12460272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Compositions and methods for amplifying or detecting varicella-zoster virus
[patent_app_type] => utility
[patent_app_number] => 17/281543
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43270
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281543 | Compositions and methods for amplifying or detecting varicella-zoster virus | Sep 30, 2019 | Issued |
Array
(
[id] => 17314942
[patent_doc_number] => 20210403990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DIGITAL AMPLIFICATION FOR PROTEIN DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/279275
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279275 | Digital amplification for protein detection | Sep 24, 2019 | Issued |
Array
(
[id] => 17336482
[patent_doc_number] => 20220002813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => IDENTIFICATION OF MOLECULAR BIOMARKERS THAT ARE PREDICTIVE OF THE RESPONSE TO RADIOCHEMOTHERAPY TREATMENT IN CERVIX CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/282731
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282731 | IDENTIFICATION OF MOLECULAR BIOMARKERS THAT ARE PREDICTIVE OF THE RESPONSE TO RADIOCHEMOTHERAPY TREATMENT IN CERVIX CARCINOMA | Sep 23, 2019 | Pending |
Array
(
[id] => 19855797
[patent_doc_number] => 12258621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => High-throughput method for detecting chromosomal aberrations and/or telomere aberrations
[patent_app_type] => utility
[patent_app_number] => 17/277507
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7602
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277507 | High-throughput method for detecting chromosomal aberrations and/or telomere aberrations | Sep 16, 2019 | Issued |
Array
(
[id] => 17400000
[patent_doc_number] => 20220042090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PROGRAMMABLE RNA-TEMPLATED SEQUENCING BY LIGATION (rSBL)
[patent_app_type] => utility
[patent_app_number] => 17/275928
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275928 | PROGRAMMABLE RNA-TEMPLATED SEQUENCING BY LIGATION (rSBL) | Sep 12, 2019 | Abandoned |
Array
(
[id] => 17414383
[patent_doc_number] => 20220049287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Colorimetric sensing polymerase chain reaction (PCR)
[patent_app_type] => utility
[patent_app_number] => 17/275317
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275317 | Colorimetric sensing polymerase chain reaction (PCR) | Sep 12, 2019 | Abandoned |
Array
(
[id] => 17097266
[patent_doc_number] => 20210285057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD FOR ESTIMATING BREAST CANCER CELL EXISTENCE RATIO
[patent_app_type] => utility
[patent_app_number] => 17/275871
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275871 | METHOD FOR ESTIMATING BREAST CANCER CELL EXISTENCE RATIO | Sep 10, 2019 | Abandoned |
Array
(
[id] => 19457939
[patent_doc_number] => 12098419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-24
[patent_title] => Linked target capture and ligation
[patent_app_type] => utility
[patent_app_number] => 17/269515
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 14125
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269515
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269515 | Linked target capture and ligation | Aug 22, 2019 | Issued |
Array
(
[id] => 19904365
[patent_doc_number] => 12281361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Methylation modification-based tumor marker STAMP-EP2
[patent_app_type] => utility
[patent_app_number] => 17/250458
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 1880
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250458 | Methylation modification-based tumor marker STAMP-EP2 | Jul 18, 2019 | Issued |